EVONANO is a H2020 EU project that gathers six research partners and one industrial partner with complementary expertise to create an integrated platform for the development and artificial evolution of novel cancer treatment strategies using nanoparticles. This working group will create a complete development pipeline for nanoparticle-based therapies, ensuring the creation of safe, efficient and personalized treatments for different types of cancer.


Group Location
University of the West of England (UWE) The Unconventional Computing Group,
Bristol, UK
Åbo Akademi University (AAU) The Embedded Systems Laboratory,
Åbo, Finland
Vall d’Hebron Research Institute (VHIR) Vall d’Hebron Research Institute,
Barcelona, Spain
University of Novi Sad (PFNS) Faculty of Agriculture,
Novi Sad, Serbia
University of Bristol Department of Engineering Mathematics,
Bristol Robotics Laboratory,
Life Sciences, Bristol, UK
IMDEA IMDEA Nanosciencia,
Madrid, Spain
ProChimia Surfaces (PCS) ProChimia Surfaces,
Sopot, Poland


Please contact EVONANO if you have any enquiries through:

Igor Balaz (Principal Investigator): [email protected]

Scott McCormick (Communications Manager): [email protected]